93 results
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
to injury. NAFLD may evolve into NASH when the fatty liver begins to progress through stages of cell injury, inflammation, fibrosis … injury to the liver leads to many genetic mutations that eventually lead to transformation of cells and formation of tumors. The noxious tissue
8-K
EX-99.1
nonpk 95xcdjd8
24 Jul 23
Regulation FD Disclosure
4:04pm
424B5
tnb1gzpohy1wa smzjkp
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.2
qpcdpxiu
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
pu2ii5bvd2 06xtw
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
t30mddxgt169t3c8i
17 Oct 22
Regulation FD Disclosure
5:13pm
8-K
EX-99.1
unfk9vuy7xd43
27 May 22
Regulation FD Disclosure
8:44am
8-K
EX-99.1
c6pk38b txh6ggxz0s8
10 Jan 22
Regulation FD Disclosure
6:02am
8-K
EX-99.2
xyvs2gl7 0ovb4pmkyk
10 Nov 21
Hepion Pharmaceuticals Announces Poster Details for the Upcoming AASLD The Liver Meeting® 2021
9:41am